Expertise area
Next-generation risk assessment (NGRA)
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Top organizations
Most active in this area
- CERTARA UK LIMITED
Commercial biosimulation company specializing in computational toxicology, PBPK modelling, and next-generation drug safety risk assessment.
“RISK-HUNT3R (2021-2026) explicitly targets human-centric next-generation testing strategies, their most recent and largest-funded project.”
UK6 projects - MEDBIOINFORMATICS SOLUTIONS SL
Barcelona SME specialising in computational toxicology, drug safety data integration, and next-generation chemical risk assessment for pharma and regulatory clients.
“RISK-HUNT3R (2021–2026) directly applies human-centric next-generation testing strategies including exposure modelling, systems toxicology, and AOP-based frameworks for regulatory acceptance.”
PrimarySMEES2 projects